Announce Date | 08/20/2025 |
EPS Normalized Actual | $4.33 (Beat by $0.09) |
EPS GAAP Actual | $4.33 (Beat by $0.09) |
Revenue Actual | $20.93B |
Revenue Surprise | Beat by $20930M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jan 2030 | 19.3 | 13.42 | 18.94579 | 19.84845 | 4 |
Feb 2029 | 18.435 | 14.05 | 17.74142 | 18.88378 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 2.93 | 2.93 | 20.93B | 100% | 20930M |
FQ1 2025 (Jan 2025) | 2 | 2 | 18.553B | 100% | 18553M |
FQ4 2024 (Nov 2024) | 2.98 | 2.98 | 20.17B | 100% | 20170M |
FQ3 2023 (Jul 2023) | 4.56 | 4.56 | 24.956B | -10.1% | 24956M |
FQ2 2023 (Apr 2023) | 3.78 | 3.78 | 22.347B | -5.87% | 22347M |
FQ2 2022 (Apr 2022) | 3.53 | 3.53 | 23.659B | 100% | 23659M |
FQ3 2022 (Jul 2022) | 4.69 | 4.69 | 27.476B | 100% | 27476M |
FQ4 2022 (Oct 2022) | 0.25 | 0.25 | 23.479B | 100% | 23479M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 3.71 | -- | 3.67536 | 3.8901 | 13 |
FQ3 2027 (Jul 2027) | 4.92 | -- | 4.87407 | 5.15884 | 17 |
FQ2 2027 (Apr 2027) | 3.53 | -- | 3.45943 | 3.61922 | 10 |
FQ1 2027 (Jan 2027) | 2.2916 | -- | 2.2353 | 2.33832 | 16 |
FQ4 2026 (Oct 2026) | 3.6405 | -- | 3.57106 | 3.73205 | 8 |
FQ3 2026 (Aug 2026) | 4.5748 | -- | 4.5748 | 4.5748 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 21.76B | -- | 21.6B | 22.57B | 24 |
FQ3 2027 (Jul 2027) | 25.22B | -- | 25.04B | 26.16B | 21 |
FQ2 2027 (Apr 2027) | 22.39B | -- | 22.04B | 22.82B | 10 |
FQ1 2027 (Jan 2027) | 20.2B | -- | 19.82B | 20.52B | 9 |
FQ4 2026 (Oct 2026) | 22.02B | -- | 21.7B | 22.45B | 14 |
FQ3 2026 (Aug 2026) | 24.69B | -- | 24.69B | 24.69B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 2.93 | 2.93 | 100% | |
FQ1 2025 (Jan 2025) | 2 | 2 | 100% | |
FQ4 2024 (Nov 2024) | 2.98 | 2.98 | 100% | |
FQ3 2023 (Jul 2023) | 4.56 | 4.56 | 100% | |
FQ2 2023 (Apr 2023) | 3.78 | 3.78 | 100% | |
FQ2 2022 (Apr 2022) | 3.53 | 3.53 | 100% | |
FQ3 2022 (Jul 2022) | 4.69 | 4.69 | 100% | |
FQ4 2022 (Oct 2022) | 0.25 | 0.25 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $20.93B | $20930M | 100% |
FQ1 2025 (Jan 2025) | $0B | $18.55B | $18553M | 100% |
FQ4 2024 (Nov 2024) | $0B | $20.17B | $20170M | 100% |
FQ3 2023 (Jul 2023) | $0B | $24.96B | $24956M | 100% |
FQ2 2023 (Apr 2023) | $0B | $22.35B | $22347M | 100% |
FQ2 2022 (Apr 2022) | $0B | $23.66B | $23659M | 100% |
FQ3 2022 (Jul 2022) | $0B | $27.48B | $27476M | 100% |
FQ4 2022 (Oct 2022) | $0B | $23.48B | $23479M | 100% |